Chemical basis of inflammation-induced carcinogenesis

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Hepatitis Viruses, vol. 59, International Agency for Research on Cancer, Lyon, France, 1994 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, Liver Flukes and Helicobacter pylori, vol. 61, International Agency for Research on Cancer, Lyon, France, 1994 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses, vol. 64, International Agency for Research on Cancer, Lyon, France, 1995 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Immunodeficiency Viruses and Human T-cell Lymphotropic Viruses, vol. 67, International Agency for Research on Cancer, Lyon, France, 1996 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Epstein–Barr Viruses and Kaposi’s Sarcoma Herpesviruses/Human Herpesvirus 8, vol. 70, International Agency for Research on Cancer, Lyon, France, 1997 Parkin, 2001, Lancet Oncol., 2, 533, 10.1016/S1470-2045(01)00486-7 D.M. Parkin, UICC Symposium ‘Asian Cancer Prevention—Today and Tomorrow.’ The first APOCP conference ‘Inflammation and Cancer’ (2002) 24 (abstract) zur Hauzen, 1999, 107 Karp, 1999, 131 Wu, 1999, Biochemistry, 38, 3538, 10.1021/bi982401l Brennan, 2002, J. Biol. Chem., 277, 17415, 10.1074/jbc.M112400200 Zhang, 2002, J. Biol. Chem., 277, 46116, 10.1074/jbc.M209124200 Warzocha, 1998, Blood, 91, 3574, 10.1182/blood.V91.10.3574 Oh, 2000, J. Urol., 163, 1584, 10.1016/S0022-5347(05)67683-5 El Omar, 2000, Nature, 404, 398, 10.1038/35006081 Beckman, 1996, Am. J. Physiol., 271, C1424, 10.1152/ajpcell.1996.271.5.C1424 Ducrocq, 1999, Cell. Mol. Life Sci., 55, 1068, 10.1007/s000180050357 Eiserich, 1996, J. Biol. Chem., 271, 19199, 10.1074/jbc.271.32.19199 Saran, 1999, Free Radic. Biol. Med., 26, 482, 10.1016/S0891-5849(98)00187-7 Henderson, 1999, J. Biol. Chem., 274, 33440, 10.1074/jbc.274.47.33440 Wentworth, 2002, Science, 298, 2195, 10.1126/science.1077642 Wentworth, 2003, Proc. Natl Acad. Sci. USA, 100, 1490, 10.1073/pnas.0437831100 Dizdaroglu, 1994, Methods Enzymol., 234, 3, 10.1016/0076-6879(94)34072-2 Christen, 1999, 35 Kasai, 1997, Mutat. Res., 387, 147, 10.1016/S1383-5742(97)00035-5 Toyokuni, 1997, Lab. Invest., 76, 365 Helbock, 1998, Proc. Natl. Acad. Sci. USA, 95, 288, 10.1073/pnas.95.1.288 Ravanat, 2002, Carcinogenesis, 23, 1911, 10.1093/carcin/23.11.1911 Niles, 2001, Org. Lett., 3, 963 Suzuki, 2001, Chem. Res. Toxicol., 14, 1163, 10.1021/tx010024z Burrows, 2002, Environ. Health Perspect., 110, 713, 10.1289/ehp.02110s5713 Masuda, 2001, J. Biol. Chem., 276, 40486, 10.1074/jbc.M102700200 London, 1997, Cancer Res., 57, 5001 Cascorbi, 2000, Cancer Res., 60, 644 Suzuki, 2002, Nucleic Acids Res., 30, 2555, 10.1093/nar/30.11.2555 Suzuki, 2003, Chem. Res. Toxicol., 16, 382, 10.1021/tx025638y Shen, 2001, Biochemistry, 40, 2041, 10.1021/bi001961t Henderson, 2001, Proc. Natl. Acad. Sci. USA, 98, 1631, 10.1073/pnas.98.4.1631 Stamler, 1992, Science, 258, 1898, 10.1126/science.1281928 Koppenol, 1996, Methods Enzymol., 268, 7, 10.1016/S0076-6879(96)68005-7 Wink, 1996, 403 Ohshima, 1994, Mutat. Res., 305, 253, 10.1016/0027-5107(94)90245-3 Ohshima, 1999, Methods Enzymol., 301, 40, 10.1016/S0076-6879(99)01067-8 Szabo, 1997, Nitric Oxide Biol. Chem., 1, 373, 10.1006/niox.1997.0143 Yermilov, 1995, FEBS Lett., 376, 207, 10.1016/0014-5793(95)01281-6 Masuda, 2002, Chem. Biol. Interact., 139, 187, 10.1016/S0009-2797(01)00299-X Byun, 1999, Biochemistry, 38, 2590, 10.1021/bi9822980 Akaike, 2003, Proc. Natl. Acad. Sci. USA, 100, 685, 10.1073/pnas.0235623100 Niles, 2001, J. Am. Chem. Soc., 123, 12147, 10.1021/ja004296k Douki, 1996, Free Radic. Res., 24, 369, 10.3109/10715769609088035 Niles, 1999, Proc. Natl. Acad. Sci. USA, 96, 11729, 10.1073/pnas.96.21.11729 Rusche, 1998, Biochemistry, 37, 15503, 10.1021/bi9813936 Adak, 2000, J. Biol. Chem., 275, 33554, 10.1074/jbc.M004337200 Nakamura, 2001, J. Biol. Chem., 276, 34402, 10.1074/jbc.M103766200 Alderton, 2001, Biochem. J., 357, 593, 10.1042/bj3570593 Huisman, 2002, FASEB J., 16, 1135, 10.1096/fj.01-0890fje Ma, 1999, Proc. Natl. Acad. Sci. USA, 96, 14617, 10.1073/pnas.96.25.14617 Wink, 1998, Arch. Biochem. Biophys., 351, 66, 10.1006/abbi.1997.0565 Ohshima, 1999, Free Radic. Biol. Med., 26, 1305, 10.1016/S0891-5849(98)00327-X Kirsch, 2002, J. Biol. Chem., 277, 13379, 10.1074/jbc.M108079200 Chazotte-Aubert, 1999, J. Biol. Chem., 274, 20909, 10.1074/jbc.274.30.20909 B. Singer, H. Bartsch, Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis, vol. 150, International Agency for Research on Cancer, Lyon, France, 1999 Sawa, 1998, Cancer Epidemiol. Biomarkers Prev., 7, 1007 Kanazawa, 2000, Cancer Lett., 156, 51, 10.1016/S0304-3835(00)00439-0 Wang, 1998, Mutat. Res., 400, 99, 10.1016/S0027-5107(98)00066-9 Moraes, 1989, Nucleic Acids Res., 17, 8301, 10.1093/nar/17.20.8301 Akasaka, 1995, Biochem. Biophys. Res. Commun., 213, 74, 10.1006/bbrc.1995.2100 Tannenbaum, 1994, ACS Symp. Ser., 553, 120, 10.1021/bk-1994-0553.ch010 Felley Bosco, 1995, Carcinogenesis, 16, 2069, 10.1093/carcin/16.9.2069 Souici, 2000, Carcinogenesis, 21, 281, 10.1093/carcin/21.2.281 Shibutani, 1991, Nature, 349, 431, 10.1038/349431a0 Jeong, 1998, Chem. Res. Toxicol., 11, 550, 10.1021/tx980008a Weitzman, 1990, Blood, 76, 655, 10.1182/blood.V76.4.655.655 Gal, 1996, Proc. Natl. Acad. Sci. USA, 93, 15102, 10.1073/pnas.93.26.15102 Sandhu, 2000, Am. J. Pathol., 156, 509, 10.1016/S0002-9440(10)64755-4 Akaike, 2000, FASEB J., 14, 1447, 10.1096/fj.14.10.1447 Weitzman, 1985, Science, 227, 1231, 10.1126/science.3975611 Ohshima, 1990, Food Chem. Toxicol., 28, 647, 10.1016/0278-6915(90)90173-K Ischiropoulos, 1998, Arch. Biochem. Biophys., 356, 1, 10.1006/abbi.1998.0755 Ohshima, 1999, Nitric Oxide, 3, 132, 10.1006/niox.1999.0216 Eiserich, 1998, Nature, 391, 393, 10.1038/34923 Wu, 1999, J. Biol. Chem., 274, 25933, 10.1074/jbc.274.36.25933 Hazen, 1996, J. Clin. Invest., 98, 1283, 10.1172/JCI118914 Hazen, 1997, J. Clin. Invest., 99, 2075, 10.1172/JCI119379 Berlett, 1997, J. Biol. Chem., 272, 20313, 10.1074/jbc.272.33.20313 Toyokuni, 2000, Antioxid. Redox Signal., 2, 681, 10.1089/ars.2000.2.4-681 Davis, 2001, Annu. Rev. Pharmacol. Toxicol., 41, 203, 10.1146/annurev.pharmtox.41.1.203 Pignatelli, 2001, Am. J. Gastroenterol., 96, 1758, 10.1111/j.1572-0241.2001.03869.x Li, 2001, Dig. Dis. Sci., 46, 836, 10.1023/A:1010764720524 Pignatelli, 2001, Cancer Res., 61, 778 Calmels, 1997, Cancer Res., 57, 3365 Cobbs, 2001, Arch. Biochem. Biophys., 394, 167, 10.1006/abbi.2001.2540 Chazotte-Aubert, 2000, Biochem. Biophys. Res. Commun., 267, 609, 10.1006/bbrc.1999.2003 Lander, 1995, J. Biol. Chem., 270, 7017, 10.1074/jbc.270.36.21195 Olivier, 2002, Hum. Mutat., 19, 607, 10.1002/humu.10081 Adjei, 2001, J. Natl. Cancer Inst., 93, 1062, 10.1093/jnci/93.14.1062 Jaiswal, 2001, Cancer Res., 61, 6388 Laval, 1994, Carcinogenesis, 15, 443, 10.1093/carcin/15.3.443 Wink, 1998, Carcinogenesis, 19, 711, 10.1093/carcin/19.5.711 Mannick, 1994, Cell, 79, 1137, 10.1016/0092-8674(94)90005-1 Kim, 1997, J. Biol. Chem., 272, 31138, 10.1074/jbc.272.49.31138 Vasa, 2000, Circ. Res., 87, 540, 10.1161/01.RES.87.7.540 Hmadcha, 1999, J. Exp. Med., 190, 1595, 10.1084/jem.190.11.1595 Okamoto, 2001, J. Biol. Chem., 276, 29596, 10.1074/jbc.M102417200 Goodwin, 1999, FASEB J., 13, 1121, 10.1096/fasebj.13.10.1121 Mei, 2000, FASEB J., 14, 1188, 10.1096/fasebj.14.9.1188 Garcia-Cardena, 1998, J. Natl. Cancer Inst., 90, 560, 10.1093/jnci/90.8.560 Lejeune, 1994, J. Immunol., 152, 5077, 10.4049/jimmunol.152.10.5077 Hegardt, 2000, Cell Immunol., 200, 116, 10.1006/cimm.2000.1625 Hanahan, 2000, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Oshima, 1996, Cell, 87, 803, 10.1016/S0092-8674(00)81988-1 Ahn, 2001, Cancer Res., 61, 8357 Kisley, 2002, Cancer Res., 62, 6850 Moore, 1999, Nat. Med., 5, 828, 10.1038/10552 Suganuma, 1999, Cancer Res., 59, 4516 Weisburger, 2001, Mutat. Res., 480–481, 23, 10.1016/S0027-5107(01)00166-X Balkwill, 2001, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0 IARC Working Group on the Evaluation of Cancer Preventive Agents, IARC Handbooks of Cancer Prevention Non-Steroidal Anti-Inflammatory Drugs, vol. 1, International Agency for Research on Cancer, Lyon, France, 1997 Bartberger, 2001, Proc. Natl. Acad. Sci. USA, 98, 2194, 10.1073/pnas.041481598 Shafirovich, 2002, Proc. Natl. Acad. Sci. USA, 99, 7340, 10.1073/pnas.112202099 Bazylinski, 1985, Inorg. Chem., 24, 4285, 10.1021/ic00219a017